Victory Capital Management’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-167
| Closed | -$3.31K | – | 2640 |
|
2023
Q3 | $3.31K | Buy |
167
+9
| +6% | +$178 | ﹤0.01% | 2509 |
|
2023
Q2 | $12.1K | Sell |
158
-4
| -2% | -$306 | ﹤0.01% | 2480 |
|
2023
Q1 | $15.3K | Sell |
162
-2
| -1% | -$189 | ﹤0.01% | 2527 |
|
2022
Q4 | $15.9K | Buy |
164
+17
| +12% | +$1.65K | ﹤0.01% | 2523 |
|
2022
Q3 | $38K | Sell |
147
-27
| -16% | -$6.98K | ﹤0.01% | 2585 |
|
2022
Q2 | $32K | Sell |
174
-1
| -0.6% | -$184 | ﹤0.01% | 2585 |
|
2022
Q1 | $14K | Sell |
175
-5
| -3% | -$400 | ﹤0.01% | 2657 |
|
2021
Q4 | $29K | Sell |
180
-5
| -3% | -$806 | ﹤0.01% | 2671 |
|
2021
Q3 | $51K | Buy |
185
+4
| +2% | +$1.1K | ﹤0.01% | 2686 |
|
2021
Q2 | $72K | Sell |
181
-3
| -2% | -$1.19K | ﹤0.01% | 2640 |
|
2021
Q1 | $99K | Sell |
184
-10
| -5% | -$5.38K | ﹤0.01% | 2607 |
|
2020
Q4 | $73K | Buy |
194
+10
| +5% | +$3.76K | ﹤0.01% | 2438 |
|
2020
Q3 | $69K | Sell |
184
-11
| -6% | -$4.13K | ﹤0.01% | 2371 |
|
2020
Q2 | $96K | Sell |
195
-208
| -52% | -$102K | ﹤0.01% | 2360 |
|
2020
Q1 | $148K | Buy |
403
+39
| +11% | +$14.3K | ﹤0.01% | 2417 |
|
2019
Q4 | $257K | Buy |
364
+131
| +56% | +$92.5K | ﹤0.01% | 2250 |
|
2019
Q3 | $149K | Buy |
+233
| New | +$149K | ﹤0.01% | 2309 |
|